April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
From Oranges, a Powerful Potential Cancer Fighter
June 13, 2019 | Wayne Lewis
Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.
Young investigator wins $1 million ORIEN NOVA Grant
June 11, 2019 | Maxine Nunes
The dynamic young founder and director of City of Hope’s Precision Imaging Lab, Ammar Chaudhry, M.D., is one of the first recipients of the new ORIEN NOVA Award. The $1 million grant will fund research for his breakthrough approach to cancer imaging and diagnosis.
Breakthrough drug shows results in lung, colon cancer
June 5, 2019 | Michael Easterling
A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.
5 things to know about skin cancer with Christiane Querfeld, M.D., Ph.D.
May 24, 2019 | Kevin Chesley
Skin cancer is a largely survivable and curable form of cancer. Even its most rare and aggressive form, melanoma, has a high cure rate thanks to leading-edge treatments. But it’s still important to be careful, according to City of Hope's Christiane Querfeld, M.D., Ph.D.
Colorectal tumor biomarker may predict immunotherapy effectiveness
May 2, 2019 | Zen Vuong
The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.
Exercise Lowers Heart Disease Risk in Breast Cancer Patients
April 23, 2019 | Letisia Marquez
After taking part in a 16-week exercise intervention, women who had early-stage breast cancer, and who were also inactive and overweight or obese, had a lower risk of developing cardiovascular disease, according to a new study in JAMA Oncology.